Avaleht › 2. tüüpi diabeet › Florida › Orlando
2. tüüpi diabeet kliinilised uuringud linnas Orlando, FL
24 uuringut haiguse 2. tüüpi diabeet jaoks otsivad osalejaid linnas Orlando ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
VärbamineFaas 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · 6 mi kaugusel
- Omega Research Orlando, Altamonte Springs · 9 mi kaugusel
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
VärbamineFaas 3
- Florida Institute for Clinical Research, Orlando
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
VärbamineFaas 3
- Conquest Research, Winter Park · 5 mi kaugusel
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
VärbamineFaas 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi kaugusel
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
VärbamineFaas 3
- Research Site, Ocoee · 10 mi kaugusel
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
VärbamineFaas 3
- AURORA-2 Clinical Site, Winter Park · 5 mi kaugusel
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
VärbamineFaas 2
- Conquest Research LLC - Winter Park, Winter Park · 5 mi kaugusel
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
VärbamineFaas 2
- West Orange Endocrinology, Ocoee · 10 mi kaugusel
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
VärbamineFaas 2
- Central Florida Kidney Specialists Oakwater, Orlando
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
VärbamineFaas 3
- Research Site, Orlando
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
VärbamineFaas 2
- Conquest Research, Winter Park · 5 mi kaugusel
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
VärbamineFaas 3
- Innovus Clinical, Kissimmee · 16 mi kaugusel
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
VärbamineFaas 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · 5 mi kaugusel
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
VärbamineFaas 3
- Research Site, Orlando
- Research Site, Ocoee · 10 mi kaugusel
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
VärbamineFaas 3
- Research Site, Orlando
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
VärbamineVaatlusuuring
- Research Site, Ocoee · 10 mi kaugusel
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
VärbamineFaas 2
- Charter Research, Orlando
- AdventHealth Translational Research Institute, Orlando
Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
VärbamineTerved vabatahtlikud oodatud
- AdventHealth Translational Research Institute, Orlando
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
VärbamineFaas 3
- AdventHealth Orlando, Orlando
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
VärbamineFaas 3
- Research Site, Ocoee · 10 mi kaugusel
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
VärbamineFaas 2
- Flourish Research Orlando, Winter Park · 5 mi kaugusel
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
VärbamineFaas 2
- Florida Institute for Clinical Research LLC, Orlando
Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency
VärbamineFaas 1Terved vabatahtlikud oodatud
- Orlando Clinical Research Center (OCRC), Orlando
The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults
VärbamineTerved vabatahtlikud oodatud
- Translational Research Institute for Metabolism and Diabetes, Orlando
2. tüüpi diabeet uuringud teistes linnades
- San Antonio, TX37 uuringut
- Houston, TX31 uuringut
- Boston, MA20 uuringut
- Miami, FL19 uuringut
- Chicago, IL19 uuringut
- Dallas, TX19 uuringut
- Columbus, OH18 uuringut
- Las Vegas, NV18 uuringut
- Atlanta, GA17 uuringut
- San Diego, CA17 uuringut
- Los Angeles, CA16 uuringut
- New York City, NY16 uuringut
Muud uuringud linnas Orlando
- Mitteväikerakuline kopsuvähk44 uuringut
- Rasvumine31 uuringut
- Metastaatiline vähk29 uuringut
- Ülekaalulisus27 uuringut
- Alzheimeri tõbi25 uuringut
- Vähk (kõik liigid)24 uuringut
- Rinnavähk23 uuringut
- Munasarjavähk22 uuringut
- Haavandiline koliit22 uuringut
- Kopsuvähk21 uuringut
- Käär- ja pärasoolevähk19 uuringut
- Suur depressiivne häire19 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.